This WG will globally coordinate the exchange of knowledge, tools and results within the Action for maximizing the visibility of the Action to different stakeholders: general public, patient associations, researchers, pharmaceutical industry, clinicians, and policy makers. The content and format of the messages will be carefully adapted to the type of audience. This WG will be essential to reinforce and consolidate the collaborations of the major players in the NRF2 field and drug discovery with policy makers and other stakeholders, and to assure the sustainability of the network beyond the Action trough a functional network.